Credo Technology Group Holding Ltd - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Credo Technology Group Holding Ltd on December 6, 2023, reporting events occurring on December 5, 2023. The filing details the entry into a material definitive agreement for an underwritten public offering of the Company's ordinary shares.
Key Financial Metrics and Transaction Details
- Offering Structure: The Company agreed to sell 8,940,000 ordinary shares, while Selling Shareholders (including board members and senior management) agreed to sell 1,060,000 ordinary shares.
- Public Offering Price: $17.50 per share.
- Total Gross Proceeds: $175.0 million.
- Proceeds to Company: $156.5 million (before underwriting discounts and expenses).
- Proceeds to Selling Shareholders: $18.6 million.
- Over-Allotment Option: Underwriters were granted a 30-day option to purchase up to an additional 1,500,000 shares.
- Expected Closing Date: On or about December 8, 2023.
Note: This filing does not provide standard operating financial metrics such as revenue, net income, operating cash flow, or debt levels for a specific reporting period.
Material Changes
The primary material change is the execution of the Underwriting Agreement, which will result in a significant increase in the Company's cash liquidity upon closing. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance or management commentary on future operational outlook. The transaction is subject to customary closing conditions. The Underwriting Agreement includes standard representations, warranties, market standoff provisions, and indemnification obligations. The Company is not an emerging growth company.
Key Facts for Investor Verification
- Verify the final closing date and whether the over-allotment option was exercised.
- Confirm the net proceeds to the Company after deducting underwriting discounts and offering expenses.
- Review the specific identities of the Selling Shareholders in Schedule II of the Underwriting Agreement to assess insider selling activity.
- Check subsequent filings for the impact of this capital raise on the Company's balance sheet and cash position.